EoCene Ltd. (EOCN) income statement
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.20−0.26 (-10.63%)
Close on Nov 18, 2026Market cap $2.20MP/E –Yield –
EoCene Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -64.2%
Financial strength
- Current ratio
- 4.16
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 102.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.17
- Dividend yield
- –
See a number that looks wrong?